Nkarta, Inc. (NKTX) analyst actions
Rating and price-target actions on NKTX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NKTX overview →
2 measured NKTX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus | Press release | +2.38% | -1.34% | |
| Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications | Press release | -2.18% | -1.84% |
Keep exploring
More NKTX: earnings → · SEC filings → · NKTX overview →